Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan F Chiappa

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Lipid Research|September 17, 2025
Resolving versus non-resolving sphingolipid dynamics during macrophage activation: a time-resolved metabolic analysisNathan F Chiappa, Nidhi Lal, Edward A Botchwey
Acta Biomaterialia|August 17, 2014
Engineering in vivo gradients of sphingosine-1-phosphate receptor ligands for localized microvascular remodeling and inflammatory cell positioningMolly E Ogle, Lauren S Sefcik, Anthony O Awojoodu, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Sphingomyelinase Licensing of Mesenchymal Stromal Cells Alters Lipid and Protein Metabolites for ImmunomodulationS'Dravious A DeVeaux, Daniel C Shah, Keji Rui, et al.
Cytotherapy|February 22, 2022
Characterizing human mesenchymal stromal cells' immune-modulatory potency using targeted lipidomic profiling of sphingolipidsS'Dravious A DeVeaux, Molly E Ogle, Sofiya Vyshnya, et al.
Biomaterials Advances|May 20, 2026
Investigating FTY720-NF immunomodulation of key lipid, gene, and protein mediators to enhance oral tissue regenerationAfra I Toma, Daniel C Shah, Victoria R Duke, et al.
Iscience|March 9, 2026
Exogenous sphingomyelinase mediates MSC-derived EV biogenesis and enhances potency via repackaging of molecular cargoDaniel C Shah, S'Dravious A DeVeaux, Hongmanlin Zhang, et al.
Cytotherapy|June 4, 2026
Characterizing the effects of MSC lipid remodeling via sphingomyelinase licensing through morphological, metabolic, and secretome profilingS'Dravious A DeVeaux, Daniel C Shah, Kejie Rui, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Lipid Research|September 17, 2025
Resolving versus non-resolving sphingolipid dynamics during macrophage activation: a time-resolved metabolic analysisNathan F Chiappa, Nidhi Lal, Edward A Botchwey
Acta Biomaterialia|August 17, 2014
Engineering in vivo gradients of sphingosine-1-phosphate receptor ligands for localized microvascular remodeling and inflammatory cell positioningMolly E Ogle, Lauren S Sefcik, Anthony O Awojoodu, et al.
Biorxiv : the Preprint Server for Biology|August 8, 2025
Sphingomyelinase Licensing of Mesenchymal Stromal Cells Alters Lipid and Protein Metabolites for ImmunomodulationS'Dravious A DeVeaux, Daniel C Shah, Keji Rui, et al.
Cytotherapy|February 22, 2022
Characterizing human mesenchymal stromal cells' immune-modulatory potency using targeted lipidomic profiling of sphingolipidsS'Dravious A DeVeaux, Molly E Ogle, Sofiya Vyshnya, et al.
Biomaterials Advances|May 20, 2026
Investigating FTY720-NF immunomodulation of key lipid, gene, and protein mediators to enhance oral tissue regenerationAfra I Toma, Daniel C Shah, Victoria R Duke, et al.
Iscience|March 9, 2026
Exogenous sphingomyelinase mediates MSC-derived EV biogenesis and enhances potency via repackaging of molecular cargoDaniel C Shah, S'Dravious A DeVeaux, Hongmanlin Zhang, et al.
Cytotherapy|June 4, 2026
Characterizing the effects of MSC lipid remodeling via sphingomyelinase licensing through morphological, metabolic, and secretome profilingS'Dravious A DeVeaux, Daniel C Shah, Kejie Rui, et al.
Pageof 1